- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
HLA-DR Antibody Bra30 / MHC Class II Antibody recognizes HLA-DR, a major histocompatibility complex (MHC) class II molecule with a central role in antigen presentation and adaptive immune responses. HLA-DR is a heterodimeric cell-surface glycoprotein composed of an alpha chain encoded by HLA-DRA and a beta chain encoded by an HLA-DRB gene. Together, these chains form a peptide-binding complex that presents extracellularly derived antigenic peptides to CD4-positive T cells. Recognition of peptide-loaded HLA-DR by the T cell receptor contributes to the activation and regulation of antigen-specific immune responses.
HLA-DR is constitutively expressed by professional antigen-presenting cells, including B cells, monocytes, macrophages and dendritic cells. Expression can also be induced on additional cell populations during immune activation and inflammatory signaling. The abundance and distribution of HLA-DR are therefore widely investigated in studies of antigen-presenting cells, immune activation, transplantation, infectious disease, autoimmunity and cancer. Altered HLA-DR expression can influence communication between antigen-presenting cells and CD4-positive T cells and is an important feature of immune regulation within inflammatory and tumor microenvironments.
Clone Bra30 is a mouse monoclonal antibody characterized against a non-polymorphic determinant of HLA-DR. Published characterization placed Bra30 within a group of monoclonal antibodies recognizing an antigenic site detected on HLA-DR molecules rather than HLA-DP or HLA-DQ. Recognition of this site was reported to depend on the conformation and/or association of the HLA class II heavy and light chains, supporting interpretation of Bra30 as an antibody against an HLA-DR-associated conformational determinant rather than an allele-specific HLA-DRB reagent.
NSJ Bioreagents provides clone Bra30 as an HLA-DR Antibody for research into HLA class II biology, antigen presentation and immune-cell recognition. HLA-DR-mediated peptide presentation provides a critical molecular interface between antigen-presenting cells and helper T cells and contributes to the initiation and regulation of adaptive immunity. An MHC Class II Antibody recognizing HLA-DR can support investigation of antigen presentation, immune-cell phenotypes and mechanisms regulating cellular immune responses.
For additional information on HLA-DR biology and complementary antibody validation, visit our HLA-DR Antibody LN3 / MHC Class II Antibody page.
Optimal dilution of the HLA-DR Antibody Bra30 / MHC Class II Antibody should be determined by the researcher.
Human REH cells (a non-T, non-B leukemia cell line) were used as the immunogen for the HLA-DR Antibody Bra30.
Store the HLA-DR Antibody Bra30 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
HLA-DR antibody, MHC Class II antibody, Bra30 antibody, HLA-DR antigen antibody, Human Leukocyte Antigen DR antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.